Boron containing small molecules as antiprotozoal agents
US-10214548-B2 · Feb 26, 2019 · US
Boron-containing small molecules as antiprotozoal agents
US2019135837A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2019135837-A1 |
| Application number | US-201916241841-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jan 7, 2019 |
| Priority date | Feb 1, 2013 |
| Publication date | May 9, 2019 |
| Grant date | — |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
This invention provides, among other things, novel compounds useful for treating protozoal infections, pharmaceutical compositions containing such compounds, as well as combinations of these compounds with at least one additional therapeutically effective agent.
First claim
Opening claim text (preview).
What is claimed is: 1 . A method of killing and/or preventing the growth of a protozoa, comprising contacting the protozoa with an effective amount of 2-chloro-N-(1-hydroxy-3,3-dimethyl-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl)-4-(1H-pyrazol-1-yl)benzamide, or a pharmaceutically acceptable salt thereof, thereby killing and/or preventing the growth of the protozoa. 2 . A method of killing and/or preventing the growth of a protozoa in a human, comprising administering to the human, in need of such treatment, a therapeutically effective amount of 2-chloro-N-(1-hydroxy-3,3-dimethyl-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl)-4-(1H-pyrazol-1-yl)benzamide, or a pharmaceutically acceptable salt thereof, thereby killing and/or preventing the growth of the protozoa. 3 . A method of killing and/or preventing the growth of a parasite in a human, comprising administering to the human, in need of such treatment, a therapeutically effective amount of 2-chloro-N-(1-hydroxy-3,3-dimethyl-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl)-4-(1H-pyrazol-1-yl)benzamide, or a pharmaceutically acceptable salt thereof, thereby killing and/or preventing the growth of the parasite.
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US2019135837A1 cover?
- This invention provides, among other things, novel compounds useful for treating protozoal infections, pharmaceutical compositions containing such compounds, as well as combinations of these compounds with at least one additional therapeutically effective agent.
- Who is the assignee on this patent?
- Anacor Pharmaceuticals Inc
- What technology area does this patent fall under?
- Primary CPC classification C07F5/025. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Thu May 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).